Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
DNOW Inc
DNOW
$2.95B
| $13.4M | ﹤0.01% |
1,752,486
-135,096
| -7% | -$1.1M |
|
|
DBD
2252
DELISTED
Diebold Nixdorf Incorporated
DBD
| $13.4M | ﹤0.01% |
1,325,307
+17,946
| +1% | +$197K |
|
2253
Amphastar Pharmaceuticals
AMPH
$858M
| $13.4M | ﹤0.01% |
703,915
+14,831
| +2% | +$290K |
|
|
MNRL
2254
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $13.3M | ﹤0.01% |
696,081
+15,949
| +2% | +$306K |
|
2255
Seaboard Corp
SEB
$4.08B
| $13.3M | ﹤0.01% |
3,249
+71
| +2% | +$286K |
|
2256
Melco Resorts & Entertainment
MLCO
$2.14B
| $13.3M | ﹤0.01% |
1,321,866
+63,939
| +5% | +$841K |
|
|
CELL
2257
DELISTED
PhenomeX Inc. Common Stock
CELL
| $13.2M | ﹤0.01% |
676,436
+161,019
| +31% | +$6.12M |
|
|
TRTX
2258
TPG RE Finance Trust
TRTX
$616M
| $13.2M | ﹤0.01% |
1,068,425
+31,256
| +3% | +$400K |
|
2259
Clover Health Investments
CLOV
$2.38B
| $13.2M | ﹤0.01% |
1,789,062
+775,633
| +77% | +$6.64M |
|
|
HONE
2260
DELISTED
HarborOne Bancorp
HONE
| $13.2M | ﹤0.01% |
941,440
-10,731
| -1% | -$149K |
|
|
CNSL
2261
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $13.2M | ﹤0.01% |
1,433,030
+41,071
| +3% | +$366K |
|
2262
Ocular Therapeutix
OCUL
$2.22B
| $13.1M | ﹤0.01% |
1,312,235
+7,436
| +0.6% | +$83.5K |
|
2263
Horizon Bancorp
HBNC
$1.05B
| $13.1M | ﹤0.01% |
722,147
+431
| +0.1% | +$7.45K |
|
|
MGI
2264
DELISTED
MoneyGram International, Inc. New
MGI
| $13.1M | ﹤0.01% |
1,635,299
+391,704
| +31% | +$3.73M |
|
2265
Wabash National
WNC
$509M
| $13.1M | ﹤0.01% |
866,412
+9,242
| +1% | +$136K |
|
2266
SiriusPoint
SPNT
$2.7B
| $13.1M | ﹤0.01% |
1,412,624
+12,333
| +0.9% | +$118K |
|
2267
Sutro Biopharma
STRO
$353M
| $13.1M | ﹤0.01% |
69,198
+1,427
| +2% | +$271K |
|
|
RAD
2268
DELISTED
Rite Aid Corporation
RAD
| $13M | ﹤0.01% |
915,926
-6,541
| -0.7% | -$103K |
|
|
PRTY
2269
DELISTED
Party City Holdco Inc.
PRTY
| $13M | ﹤0.01% |
1,827,264
+16,287
| +0.9% | +$124K |
|
2270
Tucows
TCX
$134M
| $13M | ﹤0.01% |
164,281
+923
| +0.6% | +$71.2K |
|
|
CCRN
2271
DELISTED
Cross Country Healthcare
CCRN
| $13M | ﹤0.01% |
610,084
-84
| -0% | -$1.58K |
|
2272
Recursion Pharmaceuticals
RXRX
$1.78B
| $12.9M | ﹤0.01% |
562,331
+65,382
| +13% | +$1.85M |
|
|
TVRD
2273
Tvardi Therapeutics
TVRD
$22.1M
| $12.9M | ﹤0.01% |
23,254
+1,242
| +6% | +$623K |
|
2274
Fulcrum Therapeutics
FULC
$283M
| $12.9M | ﹤0.01% |
458,442
+101,850
| +29% | +$1.93M |
|
2275
PMV Pharmaceuticals
PMVP
$65.1M
| $12.9M | ﹤0.01% |
433,473
+85,292
| +24% | +$2.72M |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.